<DOC>
<DOCNO>EP-0647231</DOCNO> 
<TEXT>
<INVENTION-TITLE>
N-SUBSTITUTED 3-AZABICYCLO[3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS, ETC.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3154	A61K314045	A61K31506	C07D40314	C07D20900	A61K31505	A61K31519	C07D41700	C07D23900	C07D20700	C07D40904	C07D48704	A61K31513	A61K3140	A61K31517	A61K31403	C07D40100	C07D41714	C07D	A61K31542	A61P2500	C07D51300	A61K3133	A61K314184	A61P4300	A61P2522	C07D49500	A61K	C07D49504	C07D47100	A61K31517	C07D40300	C07D40914	A61P2500	C07D51304	A61K31505	A61K31519	C07D40104	C07D20952	A61P2524	C07D40106	A61K3140	C07D40300	A61K31395	C07D40906	A61K31513	A61K314164	C07D40306	C07D47104	C07D23900	A61K31506	C07D22100	C07D22100	A61K3133	A61K3154	C07D40900	C07D20700	C07D40304	C07D48700	A61P4300	A61P2520	C07D20902	A61K31542	A61K31395	C07D40114	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	C07D	C07D	A61K	A61K	C07D	C07D	C07D	C07D	C07D	A61K	A61K	A61K	A61K	C07D	C07D	C07D	A61K	A61P	C07D	A61K	A61K	A61P	A61P	C07D	A61K	C07D	C07D	A61K	C07D	C07D	A61P	C07D	A61K	A61K	C07D	C07D	A61P	C07D	A61K	C07D	A61K	C07D	A61K	A61K	C07D	C07D	C07D	A61K	C07D	C07D	A61K	A61K	C07D	C07D	C07D	C07D	A61P	A61P	C07D	A61K	A61K	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	C07D403	C07D209	A61K31	A61K31	C07D417	C07D239	C07D207	C07D409	C07D487	A61K31	A61K31	A61K31	A61K31	C07D401	C07D417	C07D	A61K31	A61P25	C07D513	A61K31	A61K31	A61P43	A61P25	C07D495	A61K	C07D495	C07D471	A61K31	C07D403	C07D409	A61P25	C07D513	A61K31	A61K31	C07D401	C07D209	A61P25	C07D401	A61K31	C07D403	A61K31	C07D409	A61K31	A61K31	C07D403	C07D471	C07D239	A61K31	C07D221	C07D221	A61K31	A61K31	C07D409	C07D207	C07D403	C07D487	A61P43	A61P25	C07D209	A61K31	A61K31	C07D401	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
An N-substituted 3-azabicyclo[3.2.0]heptane 

derivative of the formula I 

 
where 


R
1
is phenyl, pyridyl, thienyl or pyrrolyl, each of 
which is unsubstituted or mono- or disubstituted by 

halogen, C
1
-C
4
-alkyl, trifluoromethyl, hydroxyl, C
1
-C
4
-alkoxy, 
amino, monomethylamino, dimethylamino, 

cyano or nitro, 
R
2
is hydrogen or phenyl which is unsubstituted or 
substituted by halogen, methoxy, hydroxyl or amino, 
n
is 0, 1, 2, 3 or 4, 
R
3
is hydrogen, hydroxyl, C
1
-C
4
-alkyl or C
1
-C
4
-alkoxy, 
or together with the adjacent carbon atom is C=O or 

C=S, 
X
and Y are each C, CH, CH
2
, NH or C
1
-C
4
-alkyl-N or N, 
Z
is a direct linkage, CO, CS or CH or CH
2
 in which 
one hydrogen can be replaced by hydroxyl, amino, 

C
1
-C
4
-alkoxy or halogen, and 
A
is hydrogen, hydroxyl, amino, mercapto, C
1
-C
4
-alkylamino, 
di-C
1
-C
4
-alkylamino, C
1
-C
4
-alkylthio or C
1
-C
4
-alkoxy, 
or together with the adjacent carbon is C=O, 

or 
A
is C
3
-C
4
-alkylene which is attached to Y and which 
can contain one or two non-cumulative double bonds 

and in which one -CH or CH
2
 can be replaced by N, S,  
 

NH or N-CH
3
, and where the ring can be either monosubstituted 
by fluorine, chlorine, methyl, methoxy, 

nitro or amino or, in the case of a benzene ring, 
mono-, di- or trisubstituted by fluorine, chlorine, 

methyl, trifluoromethyl, nitro, hydroxyl, methoxy, 
amino, monomethylamino or dimethylamino, 
 
and in which the ring on the right in formula I can have 

C
1
-C
4
-alkyl, allyl or benzyl attached to N-1 and can 
contain 1-3 non-cumulative double bonds, 

and the salts thereof with physiologically tolerated 
acids. 
A compound of the formula I as claimed in claim 
1 for use for controlling diseases. 
</CLAIMS>
</TEXT>
</DOC>
